Fingolimod granted FDA Breakthrough Therapy designation...

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Fingolimod granted FDA Breakthrough Therapy designation...

Post by MSUK » Tue Dec 19, 2017 6:47 am

Fingolimod granted FDA Breakthrough Therapy designation for paediatric MS

Novartis today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for fingolimod for the treatment of children and adolescents 10 years of age or older with relapsing multiple sclerosis (MS)...Read more - http://www.ms-uk.org/fingolimod-granted ... diatric-ms

Image
MS-UK - http://www.ms-uk.org/

Post Reply
  • Similar Topics
    Replies
    Views
    Last post